Antimicrobial Stewardship for Enterobacterales Bacteremia Management

NANot yet recruitingINTERVENTIONAL
Enrollment

420

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2026

Conditions
Infections
Interventions
BEHAVIORAL

multifaceted antibiotic stewardship intervention

Group 3 wards will receive a multifaceted antibiotic stewardship intervention. Physician education will be provided as in Group 1. All consecutive patients fulfilling inclusion and exclusion criteria for study eligibility will be assessed by an Antibiotic Stewardship team. A trained nurse will first assess the patients for clinical and host criteria to determine eligibility for short-course antibiotic therapy. The antibiotic susceptibility test results and the prescribed antibiotics treatment will be reviewed. An Infectious Diseases physician will subsequently make written recommendations for the duration and choice of antibiotic therapy, and provide an appointment within 2 weeks after hospital discharge to review patients' clinical condition when indicated.

Trial Locations (1)

Unknown

Prince of Wales Hospital, Shatin

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT06257147 - Antimicrobial Stewardship for Enterobacterales Bacteremia Management | Biotech Hunter | Biotech Hunter